Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Baxter
Colorcon
Dow
Boehringer Ingelheim

Last Updated: November 28, 2022

CLINICAL TRIALS PROFILE FOR NUTRESTORE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Nutrestore

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00195013 ↗ Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy Completed Linda Vahdat Phase 3 2003-12-01 Patients with breast cancer receiving paclitaxel chemotherapy who have mild symptoms of peripheral neuropathy will receive glutamine or placebo to try and improve symptoms.
NCT00195013 ↗ Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy Completed Weill Medical College of Cornell University Phase 3 2003-12-01 Patients with breast cancer receiving paclitaxel chemotherapy who have mild symptoms of peripheral neuropathy will receive glutamine or placebo to try and improve symptoms.
NCT01576003 ↗ Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants Completed Emmaus Medical, Inc. N/A 2012-04-01 The purpose of this research study is to evaluate the effects (good and bad) of supplementation with Glutamine to that of a placebo (L-alanine), on your child and their Short Bowel Syndrome. Researchers are doing this study to see if the addition of Glutamine to oral/tube feeding (nutrition therapy) will work better by preventing bloodstream infections, improving growth, and/or changing the make-up of bacteria in your child's intestine. Glutamine is approved by the FDA for use in adults with Short Bowel Syndrome. In this study, the investigators will be assessing how well Glutamine affects Short Bowel Syndrome in children.
NCT01576003 ↗ Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants Completed Emory University N/A 2012-04-01 The purpose of this research study is to evaluate the effects (good and bad) of supplementation with Glutamine to that of a placebo (L-alanine), on your child and their Short Bowel Syndrome. Researchers are doing this study to see if the addition of Glutamine to oral/tube feeding (nutrition therapy) will work better by preventing bloodstream infections, improving growth, and/or changing the make-up of bacteria in your child's intestine. Glutamine is approved by the FDA for use in adults with Short Bowel Syndrome. In this study, the investigators will be assessing how well Glutamine affects Short Bowel Syndrome in children.
NCT01576003 ↗ Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) N/A 2012-04-01 The purpose of this research study is to evaluate the effects (good and bad) of supplementation with Glutamine to that of a placebo (L-alanine), on your child and their Short Bowel Syndrome. Researchers are doing this study to see if the addition of Glutamine to oral/tube feeding (nutrition therapy) will work better by preventing bloodstream infections, improving growth, and/or changing the make-up of bacteria in your child's intestine. Glutamine is approved by the FDA for use in adults with Short Bowel Syndrome. In this study, the investigators will be assessing how well Glutamine affects Short Bowel Syndrome in children.
NCT01576003 ↗ Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants Completed University of Colorado, Denver N/A 2012-04-01 The purpose of this research study is to evaluate the effects (good and bad) of supplementation with Glutamine to that of a placebo (L-alanine), on your child and their Short Bowel Syndrome. Researchers are doing this study to see if the addition of Glutamine to oral/tube feeding (nutrition therapy) will work better by preventing bloodstream infections, improving growth, and/or changing the make-up of bacteria in your child's intestine. Glutamine is approved by the FDA for use in adults with Short Bowel Syndrome. In this study, the investigators will be assessing how well Glutamine affects Short Bowel Syndrome in children.
NCT01576003 ↗ Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants Completed University of Michigan N/A 2012-04-01 The purpose of this research study is to evaluate the effects (good and bad) of supplementation with Glutamine to that of a placebo (L-alanine), on your child and their Short Bowel Syndrome. Researchers are doing this study to see if the addition of Glutamine to oral/tube feeding (nutrition therapy) will work better by preventing bloodstream infections, improving growth, and/or changing the make-up of bacteria in your child's intestine. Glutamine is approved by the FDA for use in adults with Short Bowel Syndrome. In this study, the investigators will be assessing how well Glutamine affects Short Bowel Syndrome in children.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Nutrestore

Condition Name

Condition Name for Nutrestore
Intervention Trials
Lymphoma 5
Multiple Myeloma 2
Peripheral Neuropathy 2
Refractory Diffuse Large B-Cell Lymphoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Nutrestore
Intervention Trials
Lymphoma 5
Multiple Myeloma 3
Neoplasms, Plasma Cell 3
Peripheral Nervous System Diseases 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Nutrestore

Trials by Country

Trials by Country for Nutrestore
Location Trials
United States 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Nutrestore
Location Trials
Texas 5
Ohio 2
Massachusetts 1
Michigan 1
New York 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Nutrestore

Clinical Trial Phase

Clinical Trial Phase for Nutrestore
Clinical Trial Phase Trials
Phase 3 1
Phase 2 4
Phase 1/Phase 2 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Nutrestore
Clinical Trial Phase Trials
Completed 4
Withdrawn 3
Recruiting 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Nutrestore

Sponsor Name

Sponsor Name for Nutrestore
Sponsor Trials
M.D. Anderson Cancer Center 7
National Cancer Institute (NCI) 3
Beth Faiman 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Nutrestore
Sponsor Trials
Other 15
Industry 4
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Merck
AstraZeneca
Medtronic
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.